Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06517446 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optokinetic Virtual Reality Stimulation in Unilateral Vestibular Hypofunction

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Oct 7, 2026 to May 7, 2026v8
  2. Start date: Jul 31, 2025 to Sep 7, 2025
    • Primary completion date: Mar 30, 2026 to Oct 7, 2025
    • Study completion date: Aug 31, 2026 to Oct 7, 2026
    v7
  3. Start date: Jun 30, 2025 to Jul 31, 2025v6 Show 4 more changesShow less
    • Enrollment target: 54 to 48
    • Study completion date: Jul 31, 2026 to Aug 31, 2026
    • Interventions: Conventional rehabilitation program based on Cawthorne Cooksey exercises (Other), Optokinetic Virtual Reality Stimulation (Other) to Conventional rehabilitation program based on Cawthorne Cooksey exercises (Other), Optokinetic Virtual Reality Stimulation (Other), VR+OKS…
    • Study arms: 2 to 3
  4. Start date: Apr 30, 2025 to Jun 30, 2025
    • Primary completion date: Dec 31, 2025 to Mar 30, 2026
    • Study completion date: May 31, 2026 to Jul 31, 2026
    v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Dec 1, 2024 to Dec 31, 2025v3 Show 4 more changesShow less
    • Start date: Aug 31, 2024 to Apr 30, 2025
    • Primary endpoints: 6 to 3
    • Study completion date: Aug 31, 2025 to May 31, 2026
    • Secondary endpoints expanded, about 8 words
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will be conducted on patients diagnosed with UVH who apply to Prof. Dr. Mete İşeri Ear, Nose and Throat Diseases Polyclinic and Güneşli Erdem Hospital Ear, Nose and Throat and Vestibular Rehabilitation Unit. Participants will be divided into 3 groups by simple randomization (closed envelope) method. To the vestibular rehabilitation group; A conventional rehabilitation program based on structured Cawthorne Cooksey exercises will be applied for 45 minutes once a week with the support of a physiotherapist for 8 weeks. To the optokinetic stimulation group; optokinetic stimulation will be given with virtual reality glasses, and to the combined group; Participants in the vestibular exercise group will receive additional optokinetic stimulation. The application will be done once a week for 8 weeks. Inclusion criteria for the study are; diagnosed with unilateral vestibular hypofunction with VNG test, between the ages of 18-65, class A+ in the System Usability Scale (SUS) and the percentage range being between 96-100%; Exclusion criteria for the study are; Bilateral vestibular hypofunction, visual impairment, neurological disorder and inability to communicate.
Trial Details
NCT Number NCT06517446
Lead Sponsor Istanbul Medipol University Hospital
Conditions
(from sponsor)		 Vestibular Hypofunction
Related terms Motion Sickness
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov